Italian Healthtech Stock News

Comer Industries S.p.A. reported past half‑year 2026 results to June 30, with sales rising to €676.31 million and net income reaching €41.18 million, lifting basic earnings per share from continuing operations to €1.44. The sharp expansion in both revenue and earnings over the prior year highlights a period of improved operating performance and higher profitability for the group. Next, we examine how this earnings-driven improvement in profitability shapes Comer Industries' broader...

As the European markets experience a buoyant phase, with indices like the STOXX Europe 600 Index reaching new highs driven by robust corporate earnings and AI-related stock recoveries, investors are keenly observing emerging opportunities. Penny stocks, though an older term, still hold significant potential for those interested in smaller or newer companies. These stocks can offer a blend of affordability and growth prospects when supported by strong financials, making them intriguing options...

Banco di Desio e della Brianza earnings spark fresh attention Banco di Desio e della Brianza (BIT:BDB) has come into focus after reporting half year 2026 net income of €76.05 million, compared with €70.39 million for the same period a year earlier. This profitability update gives investors fresh information to weigh against the stock’s recent performance and the bank’s position as an Italy focused lender serving individuals and enterprises. See our latest analysis for Banco di Desio e della...

Q2 2026 earnings put Banca Mediolanum in focus Banca Mediolanum (BIT:BMED) is in the spotlight after reporting second quarter 2026 net income of €279.4 million and first half net income of €555.5 million, both higher than the prior year figures. See our latest analysis for Banca Mediolanum. The Q2 2026 results arrive after a strong run in Banca Mediolanum's stock, with a 24.37% 90 day share price return and a 63.60% 1 year total shareholder return at a share price of €23.17, which extends...

DiaSorin S.p.A. has released its past second-quarter 2026 results, reporting sales of €315 million and net income of €46 million, broadly in line with the prior year. However, first-half 2026 figures showed slightly lower sales of €602 million and net income of €84 million compared with the same period a year earlier, highlighting pressure on profitability despite relatively steady quarterly performance. We’ll now examine how this combination of slightly higher quarterly sales but softer...

De'Longhi (BIT:DLG) is in focus after confirming full year 2026 earnings guidance with an expected mid single digit revenue growth rate, alongside half year 2026 sales of €1,676.3m and net income of €141.4m. See our latest analysis for De'Longhi. The confirmed 2026 guidance comes after a period of strong momentum in De'Longhi's stock, with a 90 day share price return of 22.52% and a 1 year total shareholder return of 48.02%. The 3 year total shareholder return of 91.17% points to a longer...

Hera earnings event draws fresh attention Hera (BIT:HER) has come into focus after reporting half year 2026 results that show higher net income and earnings per share, even though sales for the period were lower than a year earlier. See our latest analysis for Hera. Hera's share price has shown mixed performance around the latest earnings, with a 1 day share price return of 1.07% but a decline of 5.91% year to date. However, the 3 year total shareholder return of 61.10% points to stronger...

As you might know, Ariston Holding N.V. ( BIT:ARIS ) recently reported its half-yearly numbers. Overall the results...

Last week saw the newest half-year earnings release from Infrastrutture Wireless Italiane S.p.A. ( BIT:INW ), an...

It's been a good week for Leonardo S.p.a. ( BIT:LDO ) shareholders, because the company has just released its latest...

Last week, you might have seen that Prysmian S.p.A. ( BIT:PRY ) released its interim result to the market. The early...

Comer Industries comes into this earnings season with the stock around €50.4, after a steady few months of double digit percentage gains that rewarded holders who stayed patient. The headline from the full year numbers is simple. This is a margin story. Revenue for 2025 reached about €898.9m on a trailing twelve month basis while net income sat near €61.3m. That leaves a trailing net margin of 6.8%, slightly below last year’s 7.1%. For an industrial equipment supplier that depends heavily on...

Biesse came into this quarter with a bruised share price and a reputation as a turnaround story trading on hope rather than current earnings. At €5.07 the stock has tracked weaker returns over the past three months, even as many investors focused on its low price to sales and discounted cash flow gap. The headline from this earnings release is the profit squeeze. Q1 2026 revenue stood at €146.1m while the company booked a net loss of €6.3m. Losses over the trailing twelve months reached...

Cairo Communication stock has slipped in recent weeks, yet the latest quarter lands more like a reality check on profitability than a clear buying signal. Revenue in Q1 2026 came in at €229.6m, but the company swung to a net loss of €2.8m and reported a loss per share. For a media group often viewed through a low P/E and valuation discount lens, this margin squeeze is the real story. The market sees a cheap stock. The earnings print is a reminder that cheap can also mean earnings power under...

Brunello Cucinelli (BIT:BC) is back in focus after half year 2026 earnings showed sales of €749.41 million and net income of €76.12 million, with management highlighting strong momentum in the U.S. despite softer conditions in China. See our latest analysis for Brunello Cucinelli. Despite the solid half year update, Brunello Cucinelli’s share price is still down 9.51% year to date, even after a 2.95% 1 day share price return and a 22.11% three year total shareholder return that points to...

Reply stock came into this earnings season with the wind at its back, up about 16% over the past three months and trading on a P/E of 15.5x that sits below the Italian market average. The headline from this report is clear: profitability is doing the heavy lifting. Earnings over the last year grew 17.2% and net margin sits at 10.6%, modestly higher than a year ago. The market now has to decide whether that earnings trend justifies the recent rally or if expectations, helped by optimistic...

ERG stock has been grinding lower in recent weeks, with the shares down about 7% over the past month even before investors digested the latest numbers. The headline from this earnings release is margin pressure. Trailing net profit margin sits at 13.4% compared with 21.9% a year earlier, after a one off €87.7m loss pulled reported profitability down. For a renewable power producer that relies on cash yield from long lived assets, that squeeze on margins and a dividend that is not well covered...

Ferretti heads into this earnings season with its stock stuck near €2.89 and down sharply over the past quarter, even as the latest full year numbers show revenue of about €1.39b and net profit of roughly €90m. The market has been pricing in doubt, not delight. The real story in this release is margin resilience. Adjusted earnings before interest, tax, depreciation and amortisation sit near the middle teens as a percentage of sales, and management is still guiding to an EBITDA margin of about...

Banco di Desio e della Brianza comes into this earnings season with the stock up sharply over the past quarter, yet the real story sits behind that rally. Q1 2026 delivered solid banking basics, with net income of €37.6 million on revenue of €149.9 million and a trailing net profit margin of 22.5%. The catch is valuation. The P/E of 17.4x and a share price almost double a discounted cash flow estimate signal a market paying up for these numbers. The key question now is how long that premium...

Stellantis (BIT:STLAM) has attracted fresh attention after reporting a return to profit in the second quarter of 2026 and reaffirming its full year revenue guidance, highlighting stronger North American operations and ongoing restructuring efforts in Europe. See our latest analysis for Stellantis. Despite the return to profit and reaffirmed guidance, Stellantis shares have come under pressure, with the share price down 20.1% over three months and 48.9% year to date, while the 1 year total...

French inflation and a 12.4% jump in energy prices are putting fresh attention on Europe’s energy heavyweights. Higher gas and petroleum costs, along with firmer services inflation, can reshape cash flows, pricing power and investor expectations across the sector. This article looks at three European energy stocks from a health and value focused screener that appear positively exposed to these trends. You will see how each company lines up against the latest inflation data and where the...

Pirelli & C (BIT:PIRC) drew investor attention after reporting half year 2026 earnings, with net income of €299 million on sales of €3,494.5 million and ongoing progress in its high value tyre segment. See our latest analysis for Pirelli & C. At a latest share price of €6.60, Pirelli & C has seen momentum cool in the past month with a 30 day share price return of a 0.90% decline. However, the 90 day share price return of 12.82% and 1 year total shareholder return of 20.38% point to a stronger...

Amplifon (BIT:AMP) is back in focus after reporting mixed earnings for the second quarter and first half of 2026. The company posted modestly higher Q2 sales and net income, alongside weaker year to date profitability. See our latest analysis for Amplifon. Amplifon’s mixed first half earnings update appears to have reset expectations, with the share price at €12.15 after a 1 month share price return of 23.18% and a 90 day share price return of 29.26%. However, the 1 year total shareholder...

DiaSorin (BIT:DIA) is back in focus after its second quarter 2026 results, with revenue of €315 million and flat quarterly net income, along with fresh FDA clearance for a new Liaison NES assay in the U.S. See our latest analysis for DiaSorin. DiaSorin’s recent Q2 update and FDA clearance have arrived alongside a 90 day share price return of 23.85%, although the 1 year total shareholder return is down 15.07%. This indicates recent momentum following a weaker longer term experience. If...